Characteristics | No. of patients(%) |
---|---|
Gender | Â |
  Male | 20 (68.97) |
  Female | 9 (31.03) |
Age(years) | Â |
  Median | 58 |
  Range | 36-75 |
  ≥60 | 13 (44.83) |
  <60 | 16 (55.17) |
KPS scores | Â |
  ≥70 | 19 (65.52) |
  <70 | 10 (34.48) |
Pathology | Â |
  Adenocarcinoma | 18 (62.07) |
  Non-adenocarcinoma | 11 (37.93) |
RPA class | Â |
  2 | 19 (65.52) |
  3 | 10 (34.48) |
SIR scores | Â |
  ≤5 | 13 (44.83) |
  >5 | 16 (55.17) |
GPA scores | Â |
  0-1 | 13 (44.83%) |
  1.5-2 | 11 (37.93%) |
  2.5-3 | 3 (10.34%) |
  3.5 | 2 (6.90%) |
History of EGFR-TKI treatment | Â |
  Yes | 11 (37.93) |
  No | 18 (62.07) |
Number of lesions | Â |
  Mean | 3 |
  <3 | 15 (51.72) |
  ≥3 | 14 (48.28) |
Maximum lesion volume | Â |
  <3 cc | 12 (41.38) |
  ≥3 cc | 17 (58.62) |
Total volume of lesions | Â |
  <7 cc | 15 (51.72) |
  ≥7 cc | 14 (48.28) |
Total | 29 |